Effectiveness of Rhizobium as modified by mutation for resistance to antibiotics.
D001414:Bacitracin / Q000494:pharmacology; D001434:Bacteriophage Typing; D002473:Cell Wall / Q000187:drug effects; D002701:Chloramphenicol / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D007933:Leucomycins / Q000494:pharmacology; D009154:Mutation; D009355:Neomycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D012231:Rhizobium / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013559:Symbiosis / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D007933:Leucomycins; D010406:Penicillins; D001414:Bacitracin; D009675:Novobiocin; D002701:Chloramphenicol; D014640:Vancomycin; D003523:Cycloserine; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin; D014756:Viomycin